Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:        
Net loss $ (30,268) $ (54,773) $ (64,672) $ (47,876)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 16,494 4,189    
Loss on disposal of fixed assets   1,894    
Provision for doubtful accounts (113) 14    
Loss on sublease   1,211    
Stock-based compensation expense 14,734 33,491    
Change in fair value of contingent consideration (23,076) 303    
Change in deferred taxes (2,078)      
Amortization of debt issuance costs 902      
Amortization of right-of-use assets 632      
Changes in assets and liabilities:        
Accounts receivable 370 (19,907)    
Expenditures billable to clients 3,395 (6,871)    
Prepaid expenses and other assets (4,114) 5,014    
Other assets (4,568)      
Accounts payable (15,298) 4,288    
Accrued media payments 20,136 19,297    
Client advances 3,135 1,906    
Other accrued liabilities (3,177) 7,016    
Other liabilities (1,736) (600)    
Net cash used in operating activities (24,630) (3,528) 7,234 1,433
Cash flows from investing activities:        
Minority investment (2,750)      
Capital expenditures (3,777) (448)    
Acquisitions, net of cash acquired (4,589) (47,602)    
Net cash used in investing activities (11,116) (48,050)    
Cash flows from financing activities:        
Payment of contingent considerations (14,376)      
Taxes paid related to net share settlement of equity awards (9,726)      
Proceeds from the exercise of warrants   2,279    
Proceeds from issuances of stock under employee stock plans, net 1,199 7,127    
Net cash (used in) provided by financing activities (22,903) 9,406    
Net decrease in cash and cash equivalents and restricted cash (58,649) (42,172)    
Cash and cash equivalents and restricted cash, beginning of period 255,577 115,672 115,672  
Cash and cash equivalents and restricted cash, end of period 196,928 $ 73,500 $ 255,577 $ 115,672
Non-cash activities:        
Shares issued for acquisition of businesses and earn-out consideration 8,369      
Lease liabilities arising from right-of-use assets $ 4,501